BRD4: New hope in the battle against glioblastoma
The BET family proteins, comprising BRD2, BRD3 and BRD4, represent epigenetic readers of acetylated histone marks that play pleiotropic roles in the tumorigenesis and growth of multiple human malignancies, including glioblastoma (GBM). A growing body of investigation has proven BET proteins as valua...
Saved in:
Main Authors: | Weichen Duan (Author), Miao Yu (Author), Jiajia Chen (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunomodulation - hope for patient with Glioblastoma Multiforme
by: Jakub Litak, et al.
Published: (2018) -
Immunomodulation - hope for patient with Glioblastoma Multiforme
by: Jakub Litak, et al.
Published: (2018) -
BRD4: an effective target for organ fibrosis
by: Qun Wei, et al.
Published: (2024) -
BRD4 Inhibition Protects Against Acute Pancreatitis Through Restoring Impaired Autophagic Flux
by: Shuangjun Shen, et al.
Published: (2020) -
Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis
by: Zhangxu He, et al.
Published: (2022)